日本における新型コロナウイルス感染症（COVID-19）入院患者の抗凝固療法パターンと転帰に関する研究

基本情報

NCT ID

NCT04828772

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

9,282

治験依頼者名

Bristol-Myers Squibb

概要

The purpose of this study is to describe demographic and clinical characteristics of participants who are hospitalized due to coronavirus 2019 (COVID-19), treatment use for COVID-19 and COVID-19 symptoms, and composite outcomes of COVID-19. This study will also compare composite outcomes between COVID-19 participants treated with and without anticoagulant therapy during follow-up period.

対象疾患

依頼者（Sponsor）

実施施設 (1)